173 related articles for article (PubMed ID: 33629304)
1. Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastric cancer with diabetes mellitus.
Zhou Y; Liu SX; Zhou YN; Wang J; Ji R
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1339-1350. PubMed ID: 33629304
[TBL] [Abstract][Full Text] [Related]
2. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
[TBL] [Abstract][Full Text] [Related]
3. [Expression of high mobility group protein B1 in periodontal tissues and its association with hepatic lipid metabolism in diabetic rats with periodontitis].
Pei X; Meng S; Gou C; Du Q
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):6-12. PubMed ID: 32376562
[TBL] [Abstract][Full Text] [Related]
4. [The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus].
Niu S; Zhao ZG; Lyu XM; Zhao M; Wang XZ; Liu WN; Zhao W; Zhang XH; Wang Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):391-395. PubMed ID: 32482028
[No Abstract] [Full Text] [Related]
5. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW
Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223
[TBL] [Abstract][Full Text] [Related]
6. Role of Glycated High Mobility Group Box-1 in Gastric Cancer.
Kishi S; Nishiguchi Y; Honoki K; Mori S; Fujiwara-Tani R; Sasaki T; Fujii K; Kawahara I; Goto K; Nakashima C; Kido A; Tanaka Y; Luo Y; Kuniyasu H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068442
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
Nguyen AH; Detty SQ; Agrawal DK
Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
[TBL] [Abstract][Full Text] [Related]
8. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.
Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL
J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells.
Niu CC; Lin SS; Yuan LJ; Lu ML; Ueng SWN; Yang CY; Tsai TT; Lai PL
Arthritis Res Ther; 2019 Jan; 21(1):42. PubMed ID: 30704538
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 affects the development of pulmonary arterial hypertension via RAGE.
Li WJ; Hu K; Yang JP; Xu XY; Li N; Wen ZP; Wang H
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3950-3958. PubMed ID: 28975966
[TBL] [Abstract][Full Text] [Related]
11. Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance.
Qie GQ; Wang CT; Chu YF; Wang R
Int J Clin Exp Pathol; 2015; 8(6):6262-8. PubMed ID: 26261503
[TBL] [Abstract][Full Text] [Related]
12. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway.
Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z
Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437
[TBL] [Abstract][Full Text] [Related]
13. The HMGB1/RAGE Pro-Inflammatory Axis in the Human Placenta: Modulating Effect of Low Molecular Weight Heparin.
Zenerino C; Nuzzo AM; Giuffrida D; Biolcati M; Zicari A; Todros T; Rolfo A
Molecules; 2017 Nov; 22(11):. PubMed ID: 29149067
[TBL] [Abstract][Full Text] [Related]
14. RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves' Ophthalmopathy.
Łacheta D; Poślednik KB; Czerwaty K; Ludwig N; Molińska-Glura M; Kantor I; Jabłońska-Pawlak A; Miśkiewicz P; Głuszko A; Stopa Z; Brzost J; Szczepański MJ
Mediators Inflamm; 2021; 2021():8891324. PubMed ID: 33776579
[TBL] [Abstract][Full Text] [Related]
15. The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinoma.
Yaser AM; Huang Y; Zhou RR; Hu GS; Xiao MF; Huang ZB; Duan CJ; Tian W; Tang DL; Fan XG
Int J Mol Sci; 2012; 13(5):5982-5997. PubMed ID: 22754344
[TBL] [Abstract][Full Text] [Related]
16. Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma.
Ando K; Sakoda M; Ueno S; Hiwatashi K; Iino S; Minami K; Kawasaki Y; Hashiguchi M; Tanoue K; Mataki Y; Kurahara H; Maemura K; Shinchi H; Natsugoe S
Anticancer Res; 2018 Jun; 38(6):3411-3418. PubMed ID: 29848691
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of HMGB1-RAGE in Kawasaki disease with coronary artery injury.
Qian B; Huang H; Cheng M; Qin T; Chen T; Zhao J
Eur J Med Res; 2020 Mar; 25(1):8. PubMed ID: 32183905
[TBL] [Abstract][Full Text] [Related]
18. RAGE-dependent NF-kB inflammation processes in the capsule of frozen shoulders.
Yano T; Hagiwara Y; Ando A; Kanazawa K; Koide M; Sekiguchi T; Itaya N; Onoki T; Suzuki K; Tsuchiya M; Sogi Y; Yabe Y; Itoi E
J Shoulder Elbow Surg; 2020 Sep; 29(9):1884-1891. PubMed ID: 32279986
[TBL] [Abstract][Full Text] [Related]
19. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma.
Lin L; Zhong K; Sun Z; Wu G; Ding G
J Cancer Res Clin Oncol; 2012 Jan; 138(1):11-22. PubMed ID: 21947243
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands.
Yao D; Brownlee M
Diabetes; 2010 Jan; 59(1):249-55. PubMed ID: 19833897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
